ATN International just reported Q1 2026 results with the earnings call due May 7 — and the headline is a clean miss paired with a reaffirmed full-year outlook.
The tension going into this print was already well-established. Two consecutive earnings events had been punishing: the stock fell 19.2% in a single day after the March 5 report, then a further 14.5% on the following print. That backdrop made the Q1 setup unusually charged, even for a small-cap telecom. The question heading into the call is whether holding the 2026 guide is enough to arrest the pattern.
The Q1 numbers landed on the wrong side of both key lines. EPS came in at $(0.29) against a consensus estimate of $0.04 — a meaningful gap. Revenue of $182.2 million missed the $183.4 million bar. The company reaffirmed its 2026 outlook in the same release, which is the headline management will lean on during tomorrow's call. Whether investors treat the guide as credible after two consecutive surprise-to-the-downside prints is the key variable in the room.
Short positioning carries almost no weight in this setup. Short interest is just 1.05% of the free float — a level that makes short sellers a footnote rather than a driver. The ORTEX short score has drifted lower over the past week, from around 29.8 to 28.9, consistent with gradual covering rather than any build. Cost to borrow is under 1% and availability is wide. There is no squeeze dynamic here, no meaningful short conviction. The stock moves on fundamentals and sentiment, not positioning mechanics.
Options traders leaned slightly bullish into the print. The put/call ratio was running at 0.22, modestly below its 20-day average of 0.27 — not an extreme read, but directionally consistent with more call demand than put protection ahead of the release. That bullish tilt now meets a mixed earnings outcome: the guide holds, but the actuals disappointed. The 52-week range for the PCR spans 0.04 to 1.69, so the pre-earnings level was closer to the optimistic end of the spectrum.
The insider register adds a layer of context that is harder to dismiss. In mid-March, ahead of the disastrous March 5 earnings print, the Executive Chairman Michael Prior, CEO Brad Martin, and CFO Carlos Doglioli all sold shares on the same day — March 13 — followed by another cluster of sales on March 25 from Prior, Martin, and the General Counsel. The net 90-day figure is $1.13 million in sales. Trade significance scores are low (rated 1 out of 10), and the transactions are small in absolute dollar terms relative to the individuals' holdings. But the pattern — C-suite selling in the weeks surrounding a painful earnings event — is the kind of detail that institutional holders notice. Michael Prior also appears separately in the institutional holder list, with 685,937 shares, and added 23,493 shares in April. That late-April buy from the Executive Chairman is a modest but notable offset to the earlier sells.
The stock closed at $27.66 on May 5, down 3.4% on the week. Analyst coverage is thin and the most recent data is stale — the last recorded target changes date back to late 2024, with BWS Financial maintaining a Buy at $30 and Raymond James carrying a Strong Buy at $32 (as of April 2024). Both targets sit close to current levels, suggesting limited upside priced in by the sell side even before the latest miss. No fresh analyst action has been published in the six months leading up to this note.
The earnings call on May 7 is where the story settles. Management's tone on the reaffirmed 2026 outlook — and specifically how they explain the Q1 gap — will determine whether the guide provides genuine support or reads as defensive. The prior two prints are the frame: both were followed by sharp multi-day declines. How the stock behaves in the 48 hours after the call is the next data point worth tracking closely.
See the live data behind this article on ORTEX.
Open ATNI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
